Viking Therapeutics, Inc. (NASDAQ:VKTX) Receives $112.38 Average Target Price from Brokerages

Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) have been assigned an average rating of “Buy” from the nine brokerages that are currently covering the stock, MarketBeat Ratings reports. Eight investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average […]

Related Keywords

Raymond James ,Stifel Nicolaus ,William Blair ,Greg Zante ,Marianna Mancini ,Castleark Management ,Nasdaq ,Maxim Group ,Therapeutics Inc ,Cetera Advisors ,Artal Group ,Therapeutics Company Profile ,Securities Exchange Commission ,Comerica Bank ,Viking Therapeutics ,Get Free Report ,Marketbeat Ratings ,Exchange Commission ,Investment Advisers ,Get Free ,Viking Therapeutics Daily ,